Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Martin Wermke, Enriqueta Felip, Valentina Gambardella, Yasutoshi Kuboki, Daniel Morgensztern, Zohra Oum’ Hamed, Meiruo Liu, Matus Studeny & Taofeek K Owonikoko. (2022) Phase I trial of the DLL3/CD3 bispecific T-cell engager BI 764532 in DLL3-positive small-cell lung cancer and neuroendocrine carcinomas. Future Oncology 18:24, pages 2639-2649.
Read now
Read now
Gerhard Hamilton & Adelina Plangger. (2021) The Impact of NK Cell-Based Therapeutics for the Treatment of Lung Cancer for Biologics: Targets and Therapy. Biologics: Targets and Therapy 15, pages 265-277.
Read now
Read now
Articles from other publishers (17)
Sebastian Klein, Annalena Schulte, Christoph Arolt, Yuri Tolkach, Hans Christian Reinhardt, Reinhard Buettner & Alexander Quaas. (2023) Intratumoral Abundance of M2-Macrophages is Associated With Unfavorable Prognosis and Markers of T-Cell Exhaustion in Small Cell Lung Cancer Patients. Modern Pathology 36:10, pages 100272.
Crossref
Crossref
Hasan Mutlu, Hakan Bozcuk, Mehmet Artaç & İrfan Eser. (2023) First-line immune-checkpoint inhibitor treatment in extensive-disease small-cell lung cancer: A classical and network meta-analysis. Journal of Cancer Research and Therapeutics 19:8, pages 6.
Crossref
Crossref
Patrice Lazure, Aparna R. Parikh, Neal E. Ready, Marianne J. Davies, Sophie Péloquin, Jeffrey M. Caterino, Robert Lewandowski, Alexander J. Lazar & Suzanne Murray. (2022) Challenges associated with the integration of immuno-oncology agents in clinical practice. BMC Medical Education 22:1.
Crossref
Crossref
Jia-Jun Wu, Jing-Wen Huang, Kuo-Hsuan Hsu, Yen-Hsiang Huang, Kun-Chieh Chen, Jeng-Sen Tseng, Tsung-Ying Yang & Gee-Chen Chang. (2022) Thoracic radiotherapy may improve the outcome of extensive stage small cell lung carcinoma patients treated with first-line immunotherapy plus chemotherapy. Anti-Cancer Drugs 33:10, pages e842-e849.
Crossref
Crossref
Ji Hyun Lee, Ji Woong Kim, Ha Rim Yang, Seong-Won Song, Song-Jae Lee, Yeongha Jeon, Anna Ju, Narim Lee, Min-Gu Kim, Minjoo Kim, Kyusang Hwang, Jin Hwan Yoon, Hyunbo Shim & Sukmook Lee. (2022) A Fully-Human Antibody Specifically Targeting a Membrane-Bound Fragment of CADM1 Potentiates the T Cell-Mediated Death of Human Small-Cell Lung Cancer Cells. International Journal of Molecular Sciences 23:13, pages 6895.
Crossref
Crossref
Yulian Xu, Mingxian Chen, Yanpeng Ding, Feng Guo, Min Chen & Tianzhen Lu. (2021) The efficacy and safety of immune checkpoint inhibitor in patients with relapsed small‐cell lung cancer: A systematic review and meta‐analysis. Journal of Clinical Pharmacy and Therapeutics 47:4, pages 421-429.
Crossref
Crossref
Byoung Chul Cho, Kiyotaka Yoh, Ruth Perets, Adnan Nagrial, David R. Spigel, Martin Gutierrez, Dong-Wan Kim, Dusan Kotasek, Drew Rasco, Jiaxin Niu, Miyako Satouchi, Myung-Ju Ahn, Dae Ho Lee, Corinne Maurice-Dror, Shabana Siddiqi, Yixin Ren, Rachel A. Altura & Jair Bar. (2021) Anti–cytotoxic T-lymphocyte–associated antigen-4 monoclonal antibody quavonlimab in combination with pembrolizumab: Safety and efficacy from a phase I study in previously treated extensive-stage small cell lung cancer. Lung Cancer 159, pages 162-170.
Crossref
Crossref
Justyna Błach, Kamila Wojas-Krawczyk, Marcin Nicoś & Paweł Krawczyk. (2021) Failure of Immunotherapy—The Molecular and Immunological Origin of Immunotherapy Resistance in Lung Cancer. International Journal of Molecular Sciences 22:16, pages 9030.
Crossref
Crossref
Mingrui Zhu, Yi Huang, Matthew E. Bender, Luc Girard, Rahul Kollipara, Buse Eglenen-Polat, Yujiro Naito, Trisha K. Savage, Kenneth E. Huffman, Shohei Koyama, Atsushi Kumanogoh, John D. Minna, Jane E. Johnson & Esra A. Akbay. (2021) Evasion of Innate Immunity Contributes to Small Cell Lung Cancer Progression and Metastasis. Cancer Research 81:7, pages 1813-1826.
Crossref
Crossref
Dan Guo, Qiu Xie, Shuai Jiang, Ting Xie, Yaru Li, Xin Huang, Fangyuan Li, Tingting Wang, Jian Sun, Anqi Wang, Zixin Zhang, Hao Li, Xiaochen Bo, Hebing Chen & Zhiyong Liang. (2021) Synergistic alterations in the multilevel chromatin structure anchor dysregulated genes in small cell lung cancer. Computational and Structural Biotechnology Journal 19, pages 5946-5959.
Crossref
Crossref
Laura Boyero, Amparo Sánchez-Gastaldo, Miriam Alonso, José Francisco Noguera-Uclés, Sonia Molina-Pinelo & Reyes Bernabé-Caro. (2020) Primary and Acquired Resistance to Immunotherapy in Lung Cancer: Unveiling the Mechanisms Underlying of Immune Checkpoint Blockade Therapy. Cancers 12:12, pages 3729.
Crossref
Crossref
Hui-liu Zhao, Jia-hua Yu, Ling-sha Huang, Pei-zhang Li, Ming Lao, Bo Zhu & Chao Ou. (2020) Relationship between vascular endothelial growth factor -2578C > a gene polymorphism and lung cancer risk: a meta-analysis. BMC Medical Genetics 21:1.
Crossref
Crossref
Yuwen Wang, Songyun Zou, Zhuyun Zhao, Po Liu, Changneng Ke & Shi Xu. (2020) New insights into small‐cell lung cancer development and therapy. Cell Biology International 44:8, pages 1564-1576.
Crossref
Crossref
Paola De Cicco, Giuseppe Ercolano & Angela Ianaro. (2020) The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion. Frontiers in Immunology 11.
Crossref
Crossref
Huarong Cai, Haimei Zhang & Yuequan Jiang. (2020) Prognostic and Clinicopathological Value of Programmed Cell Death Ligand1 Expression in Patients With Small Cell Lung Cancer: A Meta-Analysis. Frontiers in Oncology 10.
Crossref
Crossref
Xin Chen, Norhan Amar, Yuankui Zhu, Chunguang Wang, Chunjiao Xia, Xiaoqing Yang, Dongde Wu & Mingqian Feng. (2020) Combined DLL3-targeted bispecific antibody with PD-1 inhibition is efficient to suppress small cell lung cancer growth. Journal for ImmunoTherapy of Cancer 8:1, pages e000785.
Crossref
Crossref
Giuseppe Ercolano, Maryline Falquet, Giulia Vanoni, Sara Trabanelli & Camilla Jandus. (2019) ILC2s: New Actors in Tumor Immunity. Frontiers in Immunology 10.
Crossref
Crossref